http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022221459-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef984517ad4fa88458ab2a9b88ab9961 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
filingDate | 2019-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a185fa4eb8d90349b06f6e096fdcaa0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c254f26db80f310f19c23bfcbb4d983 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc6582247901e084b3f91fc2b4f78347 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd80b3eacd0cf9cf8b46f2314ef0a2af |
publicationDate | 2022-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2022221459-A1 |
titleOfInvention | A method of predicting response to treatment in cancer patients |
abstract | A method of predicting response to chemotherapy in a patient with cancer is described. The method comprises the steps of incubating an ADCC-capable molecule, an immune response modulator, a cancer cell line that expresses a target of the ADCC-capable molecule, and a sample of the patient's blood, for a period of time, determining an ADCC response of the cancer cell line, comparing the ADCC response with a reference ADCC response, and predicting the patient's response to chemotherapy based on the comparison. In one aspect, the cancer is a HER2+ cancer, the ADCC-capable molecule is an antibody targeting HER2, and the cancer cell lines is a HER2+ cancer cell line. |
priorityDate | 2018-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 99.